Rapid Micro Biosystems (RPID) Accounts Payables (2020 - 2026)

Rapid Micro Biosystems' Accounts Payables history runs 7 years deep, the most recent figure standing at $4.7 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 77.23% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (up 77.23% YoY), while the FY2025 annual figure was $4.1 million, up 63.27% from the prior year.
• Accounts Payables came in at $4.7 million for Q1 2026 at Rapid Micro Biosystems, up from $4.1 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $5.4 million in Q4 2022 to a low of $1.2 million in Q1 2024.
• A 5-year average of $2.9 million and a median of $2.8 million in 2022 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables slumped 63.75% in 2023 and soared 126.37% in 2025, its largest moves.
• Rapid Micro Biosystems' Accounts Payables stood at $5.4 million in 2022, then slumped by 63.65% to $2.0 million in 2023, then climbed by 28.48% to $2.5 million in 2024, then soared by 63.27% to $4.1 million in 2025, then rose by 12.83% to $4.7 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $4.7 million, $4.1 million, and $3.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison